All posts by: Michael Zand

About Michael Zand

New buzz about immunotherapy – CBC.ca

Continue reading

2017-07-15 NEWS

CBC.ca

New buzz about immunotherapy
CBC.ca
If the FDA gives final approval in the fall, it will be the first time this form of immunotherapy will be commercially available to patients. So far it’s only been tried in formal clinical trial settings. “I think in the field everybody is very excited

Continue reading

2017-07-15 NEWS

Provia Labs Acquires the Vault Stem Cell Bank’s Dental Stem Cell Client Base and Distribution Agreements
Benzinga
Provia Laboratories LLC (“Provia”) completed a transaction with the Vault Biobank (“Vault”) to take over the Vault’s dental stem cell business’ client agreements and distribution agreements. As part of the terms of the transaction, Provia will provide

and more »

Continue reading

2017-07-14 NEWS

DailyNewsKs

Stem cell-based therapy for targeting skin-to-brain cancer
Science Daily
Investigators from Brigham and Women’s Hospital (BWH) and the Harvard Stem Cell Institute have a potential solution for how to kill tumor cells that have metastasized to the brain. The team has developed cancer-killing viruses that can deliver stem
Understanding how the intestine replaces and repairs itselfHarvard Gazette

all 6 news articles »

Continue reading

2017-07-14 NEWS

The Durango Herald

Novel leukemia treatment could be 1st US gene therapy
The Durango Herald
The FDA usually follows recommendations from its expert panels, but isn’t obligated to do so. The therapy could be the first of a wave of treatments custom-made to target a patient’s cancer. Called CART, this type of therapy involves removing immune

Continue reading

2017-07-14 NEWS

NJTV News

Gene therapy one step closer to FDA approval
NJTV News
Not only did he get the gist, Justin was determined to beat it and a new gene therapy has become his best weapon. Scientists are reporting unprecedented success with a new T-cell treatment, using the patient’s own immune system to fight the cancer.

Continue reading

2017-07-14 NEWS

WBUR

What Families Need to Know About First Gene Therapy for Deadly Childhood Cancer
ConsumerReports.org
An advisory panel to the Food and Drug Administration earlier this week unanimously recommended approving a breakthrough genetic therapy to treat a rare but deadly type of childhood cancer. Here’s why the news has cancer researchers excited—and …
FDA Panel Recommends Approval of Novel ‘Gene Therapy‘ for LeukemiaWBUR
Novel leukemia treatment could be 1st US gene therapySumter Item
FDA Gives A Nod To “Paradigm Shifting” Cancer TreatmentWNPR News
BabyCenter (blog) –Medical Daily
all 25 news articles »